|
Dr. Patton is co-Founder and Vice President Research of Nektar Therapeutics (Nasdaq-NKTR) (formerly Inhale Therapeutic Systems) and has served as Chief Scientific Officer since November 2001 and as a director since July 1990. He is an expert in the delivery of peptides and proteins. Before co-founding Inhale Therapeutics Systems Dr. Patton led the drug delivery group at Genentech Inc. where he demonstrated the feasibility of systemic delivery of large molecules through the lungs. Prior to joining Genentech Inc. he was a tenured professor at the University of Georgia. He has published a wide range of articles and has presented his work in national and international arenas. Dr. Patton received his Ph.D. in Biology from the University of California San Diego and held post-doctoral positions in biomedicine at Harvard Medical School and the University of Lund in Sweden. Dr. Patton chairs our Scientific and Clinical Advisory Board. | 